Clinical usefulness of the CSF β-amyloid Aβ1-42/Aβ1-40 ratio for Alzheimer's disease diagnosis: a retrospective study in a Belgian academic hospital

被引：0
作者：
Deltombe, Matthieu [1 ,2 ]
Fillee, Catherine [1 ,2 ]
van Pesch, Vincent [3 ,4 ]
机构：
[1] Clin Univ St Luc, Dept Clin Biochem, Brussels, Belgium
[2] Catholic Univ Louvain, Brussels, Belgium
[3] Clin Univ St Luc, Dept Neurol, B-1200 Brussels, Belgium
[4] Catholic Univ Louvain, UClouvain, 10 Ave Hippocrate, B-1200 Brussels, Belgium
来源：
ACTA NEUROLOGICA BELGICA | 2022年 / 122卷 / 01期
关键词：
Alzheimer; A beta 1-42; A beta 1-40; Ratio; Cerebrospinal fluid; BIOMARKERS;
D O I：
10.1007/s13760-021-01846-4
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：245 / 247
页数：3
相关论文
共 50 条
  • [31] Preservation of Biomarkers Associated with Alzheimer's Disease (Amyloid Peptides 1-38, 1-40, 1-42, Tau Protein, Beclin 1) in the Blood of Neonates after Perinatal Asphyxia
    Tarkowska, Agata
    Furmaga-Jablonska, Wanda
    Bogucki, Jacek
    Kocki, Janusz
    Pluta, Ryszard
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (17)
  • [32] Relationship between apoE genotype and CSF β-amyloid (1-42) and tan in patients with probable and definite Alzheimer's disease
    Tapiola, T
    Pirttilä, T
    Mehta, PD
    Alafuzoff, I
    Lehtovirta, M
    Soininen, H
    NEUROBIOLOGY OF AGING, 2000, 21 (05) : 735 - 740
  • [33] Interrelations between CSF Soluble AβPPβ, Amyloid-β 1-42, SORL1, and Tau Levels in Alzheimer's Disease
    Alexopoulos, Panagiotis
    Guo, Liang-Hao
    Tsolakidou, Amalia
    Kratzer, Martina
    Grimmer, Timo
    Westerteicher, Christine
    Jiang, Meizi
    Bujo, Hideaki
    Diehl-Schmid, Janine
    Kurz, Alexander
    Perneczky, Robert
    JOURNAL OF ALZHEIMERS DISEASE, 2012, 28 (03) : 543 - 552
  • [34] Plasma Levels of Amyloid β1-42 Are Independent of Neuronal Function in Alzheimer's Disease
    Sedaghat, Fereshteh
    Dedousi, Eleni
    Costa, Vasiliki
    Dimitriadis, Athanasios S.
    Baloyannis, Stavros J.
    JOURNAL OF ALZHEIMERS DISEASE, 2009, 17 (02) : 343 - 348
  • [35] Diagnostic performance of plasma pTau217, pTau181, Aβ1-42 and Aβ1-40 in the LUMIPULSE automated platform for the detection of Alzheimer disease
    Arranz, Javier
    Zhu, Nuole
    Rubio-Guerra, Sara
    Rodriguez-Baz, Inigo
    Ferrer, Rosa
    Carmona-Iragui, Maria
    Barroeta, Isabel
    Illan-Gala, Ignacio
    Santos-Santos, Miguel
    Fortea, Juan
    Lleo, Alberto
    Tondo, Mireia
    Alcolea, Daniel
    ALZHEIMERS RESEARCH & THERAPY, 2024, 16 (01)
  • [36] Default mode network connectivity is linked to cognitive functioning and CSF Aβ1-42 levels in Alzheimer's disease
    Celebi, Ozlem
    Uzdogan, Andac
    Oguz, Kader Karli
    Has, Arzu Ceylan
    Dolgun, Anil
    Cakmakli, Gul Yalcin
    Akbiyik, Filiz
    Elibol, Bulent
    Saka, Esen
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2016, 62 : 125 - 132
  • [37] Predicting clinical decline and conversion to Alzheimer's disease or dementia using novel Elecsys Aβ(1-42), pTau and tTau CSF immunoassays
    Blennow, Kaj
    Shaw, Leslie M.
    Stomrud, Erik
    Mattsson, Niklas
    Toledo, Jon B.
    Buck, Katharina
    Wahl, Simone
    Eichenlaub, Udo
    Lifke, Valeria
    Simon, Maryline
    Trojanowski, John Q.
    Hansson, Oskar
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [38] Patients with mild cognitive impairment and a reduced CSF Aβ1-42 protein progress rapidly to Alzheimer's disease
    Monge-Argiles, J. A.
    Sanchez-Paya, J.
    Munoz-Ruiz, C.
    Pampliega-Perez, A.
    Gomez-Lopez, M. J.
    Rodriguez Borja, E.
    Montoya-Gutierrez, J.
    Leiva-Santana, C.
    NEUROLOGIA, 2012, 27 (01): : 28 - 33
  • [39] Inhibitory Effect of β-Casein on the Amyloid Fibril Formation of Aβ1-40 Associated with Alzheimer's Disease
    Ghahghaei, Arezou
    Shahraki, Sima
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2016, 22 (01) : 23 - 29
  • [40] Decreased serum amyloid β1-42 autoantibody levels in Alzheimer's disease, determined by a newly developed immuno-precipitation assay with radiolabeled amyloid β1-42 peptide
    Brettschneider, S
    Morgenthaler, NG
    Teipel, SJ
    Fischer-Schulz, C
    Bürger, K
    Dodel, R
    Du, YS
    Möller, HJ
    Bergmann, A
    Hampel, H
    BIOLOGICAL PSYCHIATRY, 2005, 57 (07) : 813 - 816
12345